Addison R. Tolentino
Hematology | Oncology
4321 Washington St Ste 4000
Kansas City, MO 64111
Kansas City, MO 64111
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Successful rechallenge of BRAF/MEK inhibitor with ruxolitinib in BRAF/MEK inhibitor-induced hemophagocytic lymphohistiocytosis like hyperinflammatory syndrome in BRAF V600E-mutated lung adenocarcinoma: a case report.
Journal: Frontiers in oncology
Published: January 24, 2026
Patient-Defined Treatment Success: Perspectives of Patients With Advanced-Stage Lung Cancer.
Journal: Journal of oncology practice
Published: July 20, 2019
Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer.
Journal: BMC cancer
Published: January 24, 2019
BRAF V600Q-mutated lung adenocarcinoma with duodenal metastasis and extreme leukocytosis.
Journal: World journal of clinical oncology
Published: April 08, 2017
Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study.
Journal: Journal of geriatric oncology
Published: December 03, 2015
Coping with an Advanced Stage Lung Cancer Diagnosis: Patient, Caregiver, and Provider Perspectives on the Role of the Health Care System.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: April 23, 2015
Engaging patients and caregivers in patient-centered outcomes research on advanced stage lung cancer: insights from patients, caregivers, and providers.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: April 19, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026